US 11648267
Methods and compositions for gene inactivation
granted A61KA61K2035/124A61K2239/31
Quick answer
US patent 11648267 (Methods and compositions for gene inactivation) held by Sangamo Therapeutics, Inc. expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2035/124, A61K2239/31, A61K2239/38, A61K35/12